Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease

1 Sept 2001

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Hormones and Disorders
Share to Ophthalmology and Eye Disorders
Share to Thyroid Disorders and Treatments

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 11583755
DOI: 10.1016/s0140-6736(01)06125-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' diseasePMID 11583755Read ↗

Association of CTLA-4 gene polymorphism with Graves' disease and ophthalmopathy in Iranian patients.Semantic proximity Read ↗

Graves' ophthalmopathy: pathogenesis and clinical implications.Semantic proximity Read ↗

Susceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack?Semantic proximity Read ↗

Immunopathogenesis of Graves’ ophthalmopathy: The role of the TSH receptorSemantic proximity Read ↗

The Development of Graves' Disease and the CTLA-4 Gene on Chromosome 2q33Semantic proximity Read ↗

Immunogenetics of endocrine ophthalmopathy and Graves' disease.Semantic proximity Read ↗

The development of Graves' disease and the CTLA-4 gene on chromosome 2q33.Semantic proximity Read ↗

CTLA4 polymorphisms and ophthalmopathy in Graves' disease patients: association study and meta-analysis.Semantic proximity Read ↗

Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations.Semantic proximity Read ↗

CTLA4 gene and Graves’ disease: association of Graves’ disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphismSemantic proximity Read ↗

Genetic susceptibility to Grave's disease.Semantic proximity Read ↗

HLA-DRB1*03 is a susceptibility gene in patients with Graves' disease with and without ophthalmopathy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.